AvantGen is a San Diego-based biotechnology company founded in 2006 with Therapeutic and Research & Diagnostic divisions. With its proprietary and robust yeast display system, large natural human antibody database, fully human antibody (Germliner™) libraries and screening technologies, AvantGen’s Therapeutic Division is dedicated to novel human antibody discovery, antibody humanization, antibody affinity maturation and optimization, for therapeutic development. AvantGen collaborates with pharmaceutical and biotechnology companies to facilitate and speed their path to antibody-based therapeutic development through services, partnerships, and licensing.